The development and creation of novel therapeutic supplements and medications with exceptional efficacy in treating nephropathy is a top priority for both developed and developing nations. The antioxidant, nephroprotective, and cytotoxicity effects of green synthesized zinc nanoparticles (ZnNPs) containing Stevia rebaudiana aqueous extract were assessed in this study. The combination of Stevia rebaudiana aqueous extract with Zn nitrate solution resulted in the Zn nanoparticles production. The characteristics of Zn nanoparticles were determined using transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FT-IR), X-ray crystallography (XRD), ultraviolet–visible spectroscopy (UV–Vis) and field emission scanning electron microscopy (FESEM). The synthesized nanoparticles typically ranged in size from 20 to 30 nm. These nanoparticles displayed a crystalline structure and maintained a uniform shape. To induce diabetes, 60 mg/kg of streptozotocin was administered intraperitoneally in 50 mice (n = 10). The treatment groups received glibenclamide (0.5 mg/kg) and 100 and 200 μg/kg of Zn nanoparticles through gavage for 25 days. Additionally, there was a positive control group for comparison (treated-diabetic). On the final day, serum levels of creatinine, urea, and blood glucose were determined in the samples. Following tissue processing, 5 μm sections of kidneys were stained with periodic acid Schiff (PAS) for subsequent stereological and histopathological analysis. The groups treated with ZnNPs exhibited a notable reduction (p < 0.05) in urea and blood glucose levels (about 190 mg/dL) when compared to the diabetic group (about 500 mg/dL) that did not receive treatment. Furthermore, the treatment with a high dose of ZnNPs resulted in a significant decrease (p < 0.05) in kidney weight and volume (including vessels, interstitial tissues, collecting ducts, loop of Henle, and distal and proximal tubules), and kidney structures length (including vessels, collecting ducts, loop of Henle, and distal and proximal tubules) (p > 0.05). Based on the findings, ZnNPs can control urea and blood glucose levels while preventing kidney damage in streptozotocin-induced diabetic animals. This research proposes utilizing zinc nanoparticles synthesized from Stevia rebaudiana as a supplementary treatment for diabetes and kidney protection in developing nations.
Read full abstract